Gaba Therapeutics, Inc
GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive. By naturally increasing neurosteroids, the drug could also benefit a broad range of other neuropsychiatric and neurological disorders.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
7
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
92
organic / mo
Sign up free to see all 5 verified contacts at Gaba Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- JS
Jarett Schultz
Director · General Business & Management
EmailPhone - MS
Mario Saltarelli
CEO & CMO · Other
EmailPhone - RF
Richard Farrell
() · Other
EmailPhone
Showing 3 of 5 verified contacts
Top roles at Gaba Therapeutics, Inc
4 distinct titles indexed · top 4 shown.
- 1()
- 1ceo & cmo
- 1chairman of the board
- 1director
Sign up to unlock all 5 contacts at Gaba Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Gaba Therapeutics, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.